Bank of America
NAGE

Bank of America’s Niagen Bioscience NAGE Stock Holding History

Bank of America’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.34M Buy
304,718
+199,227
+189% +$1.08M ﹤0.01% 4352
2025
Q4 		$671K Buy
105,491
+52,414
+99% +$365K ﹤0.01% 4748
2025
Q3 		$495K Buy
53,077
+19,061
+56% +$192K ﹤0.01% 5795
2025
Q2 		$490K Buy
34,016
+8,454
+33% +$83.5K ﹤0.01% 5723
2025
Q1 		$176K Sell
25,562
-26,582
-51% -$167K ﹤0.01% 6245
2024
Q4 		$277K Buy
52,144
+24,622
+89% +$135K ﹤0.01% 5945
2024
Q3 		$100K Buy
27,522
+2,719
+11% +$8.56K ﹤0.01% 6324
2024
Q2 		$67.7K Buy
24,803
+4,392
+22% +$14.7K ﹤0.01% 6421
2024
Q1 		$71K Buy
20,411
+19,081
+1,435% +$35.3K ﹤0.01% 6393
2023
Q4 		$1.9K Sell
1,330
-1,971
-60% -$2.75K ﹤0.01% 7134
2023
Q3 		$4.82K Sell
3,301
-2,999
-48% -$4.68K ﹤0.01% 7000
2023
Q2 		$9.89K Sell
6,300
-10,169
-62% -$15.2K ﹤0.01% 6865
2023
Q1 		$25.2K Buy
16,469
+9,321
+130% +$16.6K ﹤0.01% 6692
2022
Q4 		$12K Sell
7,148
-26,504
-79% -$42K ﹤0.01% 6873
2022
Q3 		$42K Buy
33,652
+155
+0.5% +$249 ﹤0.01% 6753
2022
Q2 		$56K Sell
33,497
-759,054
-96% -$1.48M ﹤0.01% 6781
2022
Q1 		$1.95M Sell
792,551
-629,808
-44% -$1.72M ﹤0.01% 4619
2021
Q4 		$5.32M Sell
1,422,359
-8,638
-0.6% -$46.6K ﹤0.01% 3592
2021
Q3 		$8.97M Buy
1,430,997
+235,656
+20% +$1.94M ﹤0.01% 2968
2021
Q2 		$11.8M Sell
1,195,341
-239,399
-17% -$2.09M ﹤0.01% 2668
2021
Q1 		$13.4M Buy
1,434,740
+1,410,399
+5,794% +$11.2M ﹤0.01% 2426
2020
Q4 		$116K Sell
24,341
-7,544
-24% -$36.8K ﹤0.01% 5909
2020
Q3 		$127K Buy
31,885
+9,253
+41% +$44.6K ﹤0.01% 5557
2020
Q2 		$104K Buy
22,632
+18,717
+478% +$83.8K ﹤0.01% 5652
2020
Q1 		$13K Sell
3,915
-4,194
-52% -$16.1K ﹤0.01% 6296
2019
Q4 		$35K Sell
8,109
-2,522
-24% -$8.96K ﹤0.01% 6362
2019
Q3 		$42K Buy
10,631
+629
+6% +$2.68K ﹤0.01% 6379
2019
Q2 		$46K Buy
10,002
+4,696
+89% +$20K ﹤0.01% 6337
2019
Q1 		$23K Sell
5,306
-14,789
-74% -$53.3K ﹤0.01% 6470
2018
Q4 		$69K Buy
20,095
+12,839
+177% +$44.6K ﹤0.01% 6091
2018
Q3 		$31K Buy
7,256
+2,198
+43% +$9.45K ﹤0.01% 6379
2018
Q2 		$19K Sell
5,058
-12,310
-71% -$46.8K ﹤0.01% 6527
2018
Q1 		$73K Buy
17,368
+12,700
+272% +$66.5K ﹤0.01% 5891
2017
Q4 		$28K Hold
4,668
– – ﹤0.01% 6308
2017
Q3 		$20K Sell
4,668
-11,470
-71% -$41.9K ﹤0.01% 6280
2017
Q2 		$62K Buy
16,138
+3,952
+32% +$12.5K ﹤0.01% 5791
2017
Q1 		$33K Buy
12,186
+3,586
+42% +$10.2K ﹤0.01% 6108
2016
Q4 		$28K Buy
8,600
+2,743
+47% +$7.45K ﹤0.01% 6198
2016
Q3 		$18K Buy
5,857
+648
+12% +$2.38K ﹤0.01% 6177
2016
Q2 		$22K Buy
+5,209
New +$24.6K ﹤0.01% 6206

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America's NAGE Position: Q1 2026 in Review

Bank of America increased its Niagen Bioscience (NAGE) stake by 189% in Q1 2026, buying an estimated $1.08M and bringing the position to 304,718 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #4352.

Bank of America first reported a position in NAGE in Q2 2016 and has held it in 40 quarters since. The position peaked at $13.4M in Q1 2021. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Bank of America held 304,718 shares of Niagen Bioscience worth $1.34M as of Q1 2026.
  • Bank of America bought 199,227 Niagen Bioscience shares in Q1 2026, an estimated $1.08M.
  • Niagen Bioscience made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4352 holding.
  • Bank of America first reported a position in Niagen Bioscience in Q2 2016 and has held it in 40 quarters since.
  • Bank of America's Niagen Bioscience position peaked at $13.4M in Q1 2021.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.